Key result
EchoNext Mini ECG model detects reduced LVEF with ~0.77 AUROC in external validation.
Why the study?
Whether multitask ECG model outputs for structural heart disease are disease-specific or dominated by a shared component, and the implications for error patterns and artefact robustness in emergency department deployment, remained unclear.
Does the EchoNext Mini multimodal ECG model accurately discriminate structural heart disease and maintain robustness to muscle artefact in internal and external emergency department cohorts?
Cohort (n=11,068)
Yes
Does the EchoNext Mini multimodal ECG model accurately discriminate structural heart disease and maintain robustness to muscle artefact in internal and external emergency department cohorts?
The EchoNext Mini multimodal ECG model generalizes to external emergency department data for broad structural heart disease screening, though its outputs are driven by a dominant shared prediction component rather than disease-specific features.
May simplify ECG-based structural heart disease screening in the ED; leaves open prospective validation of clinical utility.
Background/Introduction Multitask ECG models are usually evaluated per label, but whether outputs are disease-specific or dominated by a shared component and the implications for error patterns and artefact robustness, remains unclear. Purpose To evaluate output-space structure, external validity, artefact robustness, and clinically relevant failure modes to inform emergency department (ED) deployment. Methods EchoNext Mini [1], a pretrained multimodal ECG model (12-lead ECG + 7 tabular covariates; 12 probability outputs for structural heart disease), was evaluated in (i) an internal ECG-echo cohort [2](n=10,068) and (ii) an external ED cohort [3] (n=1,000; cardiologist-adjudicated labels for LVEF≤45%, aortic stenosis, and tricuspid regurgitation). Discrimination was assessed using the area under the receiver operating characteristic curve (AUROC). Prediction-space structure was quantified by inter-output correlations and principal component analysis (PCA) and related to vectorcardiographic (VCG) morphology. Error profiles were compared. Muscle artefact robustness was tested in 1,000 internal ECGs by gradually adding high-pass filtered noise. Results Mean internal AUROC was 0.802 (range 0.734-0.866). External AUROCs were 0.769 (95% CI 0.74-0.80) for LVEF≤45%, 0.702 (0.64-0.76) for aortic stenosis, and 0.745 (0.7-0.79) for tricuspid regurgitation, corresponding to performance decrements of ΔAUROC 0.083, 0.157, and 0.088, respectively. PCA showed that PC1 explained 85.5% of prediction variance internally and 79.9% externally. Ground-truth labels were weakly correlated (median |r|=0.10), whereas predicted probabilities were strongly correlated (median |r|=0.89), suggesting a dominant shared prediction component. Externally PC1 separated disease strongly for LVEF≤45% and tricuspid regurgitation (p<1×10⁻¹⁸) but modestly for aortic stenosis (p=0.032). The QRS–T angle was the top single vectorcardiographic feature (e.g., AUROC 0.744 for LVEF≤45%; Cohen’s d=0.92). Robustness to muscle artefact was high overall (mean ΔAUROC −0.005 at 157 µV RMS), but across the 12 internal outputs pericardial effusion was most sensitive (ΔAUROC 0.159), while aortic stenosis was minimally affected (ΔAUROC 0.010). False positives were enriched in older patients with electrical remodelling (wider QRS, prolonged QTc, higher QRS-T angle), whereas false negatives clustered in younger patients with narrower QRS and lower QRS-T angle. Conclusion(s) The model generalised to external ED data with moderate, label-dependent performance loss. Multitask outputs were dominated by a shared prediction component aligned with VCG morphology, supporting broad screening/triage but limiting disease-specific inference from individual heads. Error profiling suggests likely false alarms in older remodelling phenotypes and missed disease in younger patients with minimal electrical changes. Muscle artefact was a minor threat overall, except for pericardial effusion.
No takes yet. Share an insight, caveat, or question.
Riedemann et al. (2026) conducted a cohort in Structural heart disease (n=11,068). EchoNext Mini multimodal ECG model vs. Cardiologist-adjudicated echocardiographic labels was evaluated on Discrimination (AUROC) for structural heart disease (specifically LVEF<=45% in external validation) (AUROC 0.769, 95% CI 0.74-0.80). The EchoNext Mini ECG model achieved external AUROCs of 0.769 (95% CI 0.74-0.80) for LVEF<=45%, 0.702 for aortic stenosis, and 0.745 for tricuspid regurgitation, driven by a shared component.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: